Bimzelx 160 mg/mL injection Images

Generic Name: bimekizumab

This medication has been identified as Bimzelx 160 mg/mL injection. It is supplied by UCB, Inc.

Bimzelx is used in the treatment of Hidradenitis Suppurativa; Psoriatic Arthritis; Ankylosing Spondylitis; Non-Radiographic Axial Spondyloarthritis; Plaque Psoriasis and belongs to the drug class interleukin inhibitors. Bimzelx 160 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Bimzelx

Generic Name

bimekizumab

Strength

160 mg/mL injection

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

UCB, Inc.

National Drug Code (NDC)

50474-0781

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer